MKI67 and hepatocellular carcinoma: Among the enrolled patients, there were 84 cases of high Ki-67 expression (> 10% immune-reactivity) HCC lesions and 36 cases of low Ki-67 expression (≤ 10% immunoreactivity) HCC lesions (see Table 1).